Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-28
1997-06-17
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514449, A01N 4308
Patent
active
056397879
ABSTRACT:
A method of treating cancer in a patient by raising and maintaining the concentration of ascorbic acid, or ascorbate, in the patient's plasma to at least the level expected to be toxic to an in vitro culture of cells of the type of cancer being treated, the required plasma ascorbate levels being achieved and maintained using long term intravenous infusions of large amounts of ascorbate, with or without ascorbate cytotoxicity effectiveness enhancing or tumor site delivery and absorption enhancing agents.
REFERENCES:
patent: 5032610 (1991-07-01), Borretzen et al.
patent: 5036103 (1991-07-01), Kochi
patent: 5117972 (1992-05-01), Ohwishi
patent: 5130145 (1992-07-01), Oftebro et al.
patent: 5135948 (1992-08-01), Borretzen et al.
Riordan, N. et al; Intravenous Ascorbate as a tumor cytotoxic chemotherapic agent, Mar. 1995 Journal of Medical Hypothesis.
Riordan Hugh D.
Riordan Neil H.
Lee Philip J.
Nutter Nathan M.
The Center for the Improvement of Human Functioning Int'l, Inc.
Williamson Michael A.
LandOfFree
Therapeutic method for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic method for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic method for the treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2158243